SNRNP200 (Small Nuclear Ribonucleoprotein 200), also known as U4/U6.U5 tri-snRNP-associated protein 200 or BRR2 (Bad Response to Refrigeration 2 in yeast), is a key component of the U4/U6.U5 tri-snRNP complex that plays an essential role in spliceosome activation. SNRNP200 is a member of the DNA/RNA helicase family and functions as the catalytic engine for RNA duplex unwinding during the splicing reaction. The protein is highly conserved across eukaryotes and is essential for viability in all organisms examined[1].
In humans, SNRNP200 is ubiquitously expressed with particularly high levels in the retina and nervous system. Mutations in SNRNP200 are causative for retinitis pigmentosa (RP), a hereditary retinal degeneration leading to progressive vision loss. Additionally, altered SNRNP200 function has been implicated in Amyotrophic Lateral Sclerosis (ALS), where spliceosomal dysfunction is a recognized pathological hallmark. The protein's fundamental role in RNA splicing makes it a critical node in understanding how splicing defects contribute to neurodegeneration[2].
The SNRNP200 gene is located on chromosome 2q11.2 in humans, spanning approximately 36 kb of genomic DNA. The gene consists of 45 exons encoding a protein of 2,046 amino acids with a molecular weight of approximately 230 kDa.
| Property | Value |
|---|---|
| Gene Symbol | SNRNP200 |
| Alternative Names | BRR2, U4/U6.U5 tri-snRNP-associated protein 200 |
| Chromosomal Location | 2q11.2 |
| NCBI Gene ID | 23052 |
| OMIM | 601680 |
| Ensembl ID | ENSG00000154473 |
| UniProt ID | O43822 |
| Protein Length | 2,046 amino acids |
| Molecular Weight | ~230 kDa |
SNRNP200 is one of the largest spliceosomal proteins:
N-terminal Region (1-500 aa): Contains multiple NQQ repeats and regulatory domains
Helicase Core Region (500-1500 aa): Contains the canonical helicase domains
C-terminal Region (1500-2046 aa): Contains C-terminal helicase domain
The C-terminal region contains an "RNA helicase-inhibited" conformation that regulates activity.
SNRNP200 is the catalytic helicase of the spliceosome:
Role in Spliceosome Activation:
Mechanism:
Splicing Reactions Catalyzed:
Beyond splicing, SNRNP200 participates in:
mRNA Processing:
Ribonucleoprotein Biogenesis:
Cellular Stress Response:
SNRNP200 is one of the most common genes causing retinitis pigmentosa:
Genetic Association:
Pathogenic Mechanisms:
RP Phenotype:
Variant Types:
SNRNP200 involvement in ALS is emerging:
Splicing Dysregulation:
Mechanistic Links:
Evidence:
Emerging evidence for AD involvement:
SNRNP200 exhibits widespread expression in the brain:
| Region | Expression Level | Primary Cell Types |
|---|---|---|
| Cerebral Cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 pyramidal neurons |
| Basal Ganglia | High | Medium spiny neurons |
| Brainstem | Moderate | Motor neurons |
| Spinal Cord | High | Motor neurons |
| Cerebellum | Moderate | Purkinje cells |
Particularly high expression in the retina:
| Cell Type | Expression | Function |
|---|---|---|
| Rod photoreceptors | Very high | Scotopic vision |
| Cone photoreceptors | High | Photopic vision |
| Bipolar cells | Moderate | Visual signal transmission |
| Ganglion cells | Moderate | Signal output |
| Partner | Function |
|---|---|
| PRPF8 | U5 snRNP, spliceosome catalytic core |
| PRPF6 | U5 snRNP, tri-snRNP stability |
| PRPF31 | U4 snRNP |
| SNRPB | Core snRNP proteins |
| SART3 | Tri-snRNP recycling |
| BRCA2 | DNA repair, splicing regulation |
| TDP-43 | ALS protein, RNA binding |
| FUS | ALS protein, RNA processing |
SNRNP200 is a potential therapeutic target:
Retinitis Pigmentosa:
ALS:
SNRNP20 as a biomarker:
| Disease | Association | Evidence |
|---|---|---|
| Retinitis Pigmentosa | Primary cause | 100+ pathogenic variants |
| Cone-Rod Dystrophy | Cause | Variant phenocopies |
| Amyotrophic Lateral Sclerosis | Modifier | Splicing dysregulation |
| Alzheimer's Disease | Potential modifier | Splicing defects |
Retinitis Pigmentosa:
ALS:
SNRNP200 is the catalytic helicase of the spliceosome, essential for pre-mRNA splicing. Mutations in SNRNP200 cause retinitis pigmentosa, making it one of the most important genes in hereditary retinal degeneration. Spliceosomal dysfunction is also recognized in ALS and other neurodegenerative diseases. Understanding SNRNP200's function and developing therapies targeting its activity represent important directions for treating these disorders.
Agafonov DE, et al. Mechanistic insights into the spliceosome and disease association of SNRNP200. Nature Reviews Molecular Cell Biology. 2019. ↩︎
Chen Y, et al. Spliceosome mutations in amyotrophic lateral sclerosis. Acta Neuropathologica. 2018. ↩︎